Hak Healthcare Limited 31/07/2019 iXBRL

Hak Healthcare Limited 31/07/2019 iXBRL

HAK HEALTHCARE LTD - Company Information

Print Friendly Version

31/07/2019 2019-07-31 false false false false false false false false false false true false false true false false false false false false false false No description of principal activities is disclosed 2018-08-01 Sage Accounts Production 19.0 - FRS102_2014 xbrli:pure xbrli:shares iso4217:GBP 09145910 2018-08-01 2019-07-31 09145910 2019-07-31 09145910 2018-07-31 09145910 2017-08-01 2018-07-31 09145910 2018-07-31 09145910 2017-07-31 09145910 core:FurnitureFittingsToolsEquipment 2018-08-01 2019-07-31 09145910 core:MotorVehicles 2018-08-01 2019-07-31 09145910 bus:RegisteredOffice 2018-08-01 2019-07-31 09145910 bus:LeadAgentIfApplicable 2018-08-01 2019-07-31 09145910 bus:Director1 2018-08-01 2019-07-31 09145910 bus:Director2 2018-08-01 2019-07-31 09145910 bus:Director3 2018-08-01 2019-07-31 09145910 core:FurnitureFittingsToolsEquipment 2018-07-31 09145910 core:MotorVehicles 2018-07-31 09145910 core:FurnitureFittingsToolsEquipment 2019-07-31 09145910 core:MotorVehicles 2019-07-31 09145910 core:RetainedEarningsAccumulatedLosses 2017-08-01 2018-07-31 09145910 core:RetainedEarningsAccumulatedLosses 2018-08-01 2019-07-31 09145910 core:WithinOneYear 2019-07-31 09145910 core:WithinOneYear 2018-07-31 09145910 core:AfterOneYear 2019-07-31 09145910 core:AfterOneYear 2018-07-31 09145910 core:ShareCapital 2019-07-31 09145910 core:ShareCapital 2018-07-31 09145910 core:RetainedEarningsAccumulatedLosses 2019-07-31 09145910 core:RetainedEarningsAccumulatedLosses 2018-07-31 09145910 core:ShareCapital 2017-07-31 09145910 core:RetainedEarningsAccumulatedLosses 2017-07-31 09145910 core:FurnitureFittingsToolsEquipment 2018-07-31 09145910 core:MotorVehicles 2018-07-31 09145910 bus:Director1 2018-07-31 09145910 bus:Director1 2019-07-31 09145910 bus:Director2 2018-07-31 09145910 bus:Director2 2019-07-31 09145910 bus:Director3 2018-07-31 09145910 bus:Director3 2019-07-31 09145910 bus:Director1 2017-07-31 09145910 bus:Director1 2018-07-31 09145910 bus:Director2 2017-07-31 09145910 bus:Director2 2018-07-31 09145910 bus:Director3 2018-07-31 09145910 bus:Director2 2017-08-01 2018-07-31 09145910 bus:Director3 2017-08-01 2018-07-31 09145910 bus:SmallEntities 2018-08-01 2019-07-31 09145910 bus:AuditExemptWithAccountantsReport 2018-08-01 2019-07-31 09145910 bus:FullAccounts 2018-08-01 2019-07-31 09145910 bus:SmallCompaniesRegimeForAccounts 2018-08-01 2019-07-31 09145910 bus:PrivateLimitedCompanyLtd 2018-08-01 2019-07-31
Company registration number: 09145910
Hak Healthcare Limited
Unaudited filleted financial statements
31 July 2019
Hak Healthcare Limited
Contents
Directors and other information
Accountants report
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Hak Healthcare Limited
Directors and other information
Directors Dr A A Bokhari
Mrs S H Chaudry
Dr K M Syed
Company number 09145910
Registered office 1st Floor
84 North Street
Manchester
M8 8RA
Accountants Accounts Tax Solutions Limited
Paul House
Stockport Road
Timperley
Cheshire
WA15 7UQ
Hak Healthcare Limited
Report to the board of directors on the preparation of the
unaudited statutory financial statements of Hak Healthcare Limited
Year ended 31 July 2019
As described on the statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the year ended 31 July 2019 which comprise the statement of financial position, statement of changes in equity and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Accounts Tax Solutions Limited
Paul House
Stockport Road
Timperley
Cheshire
WA15 7UQ
28 April 2020
Hak Healthcare Limited
Statement of financial position
31 July 2019
2019 2018
Note £ £ £ £
Fixed assets
Tangible assets 5 5,716 6,748
_______ _______
5,716 6,748
Current assets
Stocks 16,831 15,128
Debtors 6 98,280 96,828
Cash at bank and in hand 988 9,443
_______ _______
116,099 121,399
Creditors: amounts falling due
within one year 7 ( 103,949) ( 92,987)
_______ _______
Net current assets 12,150 28,412
_______ _______
Total assets less current liabilities 17,866 35,160
Creditors: amounts falling due
after more than one year 8 ( 2,691) ( 4,590)
_______ _______
Net assets 15,175 30,570
_______ _______
Capital and reserves
Called up share capital 99 99
Profit and loss account 15,076 30,471
_______ _______
Shareholders funds 15,175 30,570
_______ _______
For the year ending 31 July 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 28 April 2020 , and are signed on behalf of the board by:
Mrs S H Chaudry
Director
Company registration number: 09145910
Hak Healthcare Limited
Statement of changes in equity
Year ended 31 July 2019
Called up share capital Profit and loss account Total
£ £ £
At 1 August 2017 99 30,944 31,043
Loss for the year ( 473) ( 473)
_______ _______ _______
Total comprehensive income for the year - ( 473) ( 473)
_______ _______ _______
At 31 July 2018 and 1 August 2018 99 30,471 30,570
Loss for the year ( 15,395) ( 15,395)
_______ _______ _______
Total comprehensive income for the year - ( 15,395) ( 15,395)
_______ _______ _______
At 31 July 2019 99 15,076 15,175
_______ _______ _______
Hak Healthcare Limited
Notes to the financial statements
Year ended 31 July 2019
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 1st Floor, 84 North Street, Manchester, M8 8RA.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fittings fixtures and equipment - 25 % reducing balance
Motor vehicles - 25 % reducing balance
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 5 (2018: 4 ).
5. Tangible assets
Fixtures, fittings and equipment Motor vehicles Total
£ £ £
Cost
At 1 August 2018 2,833 9,504 12,337
Additions 874 - 874
_______ _______ _______
At 31 July 2019 3,707 9,504 13,211
_______ _______ _______
Depreciation
At 1 August 2018 1,431 4,158 5,589
Charge for the year 569 1,337 1,906
_______ _______ _______
At 31 July 2019 2,000 5,495 7,495
_______ _______ _______
Carrying amount
At 31 July 2019 1,707 4,009 5,716
_______ _______ _______
At 31 July 2018 1,402 5,346 6,748
_______ _______ _______
6. Debtors
2019 2018
£ £
Other debtors 98,280 96,828
_______ _______
7. Creditors: amounts falling due within one year
2019 2018
£ £
Trade creditors 73,724 61,264
Corporation tax 268 268
Other creditors 29,957 31,455
_______ _______
103,949 92,987
_______ _______
8. Creditors: amounts falling due after more than one year
2019 2018
£ £
Other creditors 2,691 4,590
_______ _______
9. Directors advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2019
Balance brought forward Advances /(credits) to the directors Amounts repaid Balance o/standing
£ £ £ £
Dr A A Bokhari ( 8,869) - - ( 8,869)
Mrs S H Chaudry 11,707 357 - 12,064
Dr K M Syed ( 6,014) - - ( 6,014)
_______ _______ _______ _______
( 3,176) 357 - ( 2,819)
_______ _______ _______ _______
2018
Balance brought forward Advances /(credits) to the directors Amounts repaid Balance o/standing
£ £ £ £
Dr A A Bokhari ( 8,869) - - ( 8,869)
Mrs S H Chaudry ( 223) 11,930 - 11,707
Dr K M Syed - - ( 6,014) ( 6,014)
_______ _______ _______ _______
( 9,092) 11,930 ( 6,014) ( 3,176)
_______ _______ _______ _______
10. Controlling party
The ultimate controlling party of the company are its Directors.